(Q33735395)

29 July 2017

1 reference

title

The cyclooxygenase-2 inhibitors: safety and effectiveness (English)

1 reference

29 July 2017

B Kaplan-Machlis

1

1 reference

29 July 2017

B S Klostermeyer

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

Annals of Pharmacotherapy

29 July 2017

published in

1 reference

29 July 2017

volume

33

1 reference

29 July 2017

issue

9

1 reference

29 July 2017

page(s)

979-988

1 reference

Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology

29 July 2017

cites work

1 reference

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

Prostaglandin endoperoxide synthase: structure and catalysis

21 January 2018

1 reference

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

21 January 2018

1 reference

Review article: COX-II inhibitors--a new generation of safer NSAIDs?

21 January 2018

1 reference

In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview

21 January 2018

1 reference

Cyclooxygenase 1 and 2 in rheumatic disease: implications for nonsteroidal anti-inflammatory drug therapy

21 January 2018

1 reference

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

21 January 2018

1 reference

Future trends in the development of safer nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

21 January 2018

1 reference

21 January 2018

1 reference

Effects of meloxicam compared to acetylsalicylic acid in human articular chondrocytes

21 January 2018

1 reference

Interaction of meloxicam with cimetidine, Maalox, or aspirin.

21 January 2018

1 reference

Influence of meloxicam on furosemide pharmacokinetics and pharmacodynamics in healthy volunteers

21 January 2018

1 reference

The effect of meloxicam on the pharmacokinetics of beta-acetyl-digoxin

21 January 2018

1 reference

Comparison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients with acute sciatica

21 January 2018

1 reference

Tolerability of multiple administration of intramuscular meloxicam: a comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritis.

21 January 2018

1 reference

A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip.

21 January 2018

1 reference

Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthriti

21 January 2018

1 reference

Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium

21 January 2018

1 reference

Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.

21 January 2018

1 reference

A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis

21 January 2018

1 reference

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.18415

1 reference

29 July 2017

1 reference